Fellowship in Transfusion Medicine

The two-year fellowship training program prepares physicians for a career in transfusion medicine, providing experience in clinical, technical, investigational and administrative aspects of the field in preparation for the certifying examination in transfusion medicine/blood banking offered by the American Board of Pathology. The first year, the fellow performs clinical consultations involving component therapy and apheresis, participates in daily patient care problems, conducts clinical rounds, participates in journal club and transfusion committee as well as didactic teaching of allied health care staff including nurses, medical technologists and SBB students. The second year focuses on research opportunities that include the areas of gene therapy, transfusion-transmitted disease, advanced cellular separation and processing, molecular HLA techniques and radiolabeling.

Requirements: Applicants must be Board certified or eligible in internal medicine, hematology, clinical pathology or anesthesiology and must be U.S. citizens or resident aliens.

Stipends: Stipends are in accordance with U.S. federal government regulations for federal salary.

Applications: Fellowship appointments are effective July of each academic year. To apply, please send a letter of interest stating qualifications, a curriculum vitae and two or more letters of recommendation to:

Cathy Conry-Cantilena M.D.
Department of Transfusion Medicine, Clinical Center,
Building-lO Room 1C711, National Institutes of Health, Bethesda, MD 20892
Phone (301)496-4506 Fax (301)402-1360 E-mail: cathyc@mail.cc.nih.gov

Faculty:
Harvey G. Klein, MD, Chief, DTM, Clinical Center, NIH
Harvey J. Alter, MD, Chief, Infectious Diseases Section
Elizabeth J. Read, MD, Chief, Cell Processing Section
Susan F. Leitman, MD, Chief, Blood Services Section
David Stroncek, MD, Chief, Laboratory Services Section
Cathy Conry-Cantilena, MD, Medical Officer

Associate Faculty
Francesco Marincola, MD, Scientific Director, HLA lab, Lab Services Section
James W. Shih, Ph.D., Director Molecular Diagnostics Lab, Infectious Diseases Section